Diverse functions of neuropeptide Y revealed using genetically modified animals

被引:110
作者
Thorsell, A
Heilig, M
机构
[1] Scripps Res Inst, Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA
[2] Karolinska Inst, Dept NEUROTEC, S-14186 Huddinge, Sweden
关键词
D O I
10.1054/npep.2002.0897
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neuropeptide Y (NPY), a peptide abundantly expressed in the mammalian nervous system, has been extensively studied using traditional pharmacological and behavioral models. Central administration of NPY or synthetic ligands for its receptors has indicated a role of NPY in anxiety-related behaviors, feeding, regulation of blood pressure, circadian rhythm and other functions. Some limitations inherent in pharmacological approaches, such as lack of selectivity of receptor antagonists, can be elegantly circumvented using genetically modified animals. For NPY, mice lacking NPY, the Y1, the Y2 or the Y5 receptors have been generated. In addition, both mice and rats overexpressing NPY in the central nervous system are available. Here, we review the research carried out so far in the NPY-field using genetically modified animals. Together, these models indicate that stress-related behaviors and regulation of voluntary alcohol intake perhaps are among the most important functions of central NPY, and may provide attractive targets for developing novel therapies in depression, anxiety disorders and alcohol dependence. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:182 / 193
页数:12
相关论文
共 107 条
[1]   RECEPTOR-SELECTIVE ANALOGS DEMONSTRATE NPY PYY RECEPTOR HETEROGENEITY IN RAT-BRAIN [J].
AICHER, SA ;
SPRINGSTON, M ;
BERGER, SB ;
REIS, DJ ;
WAHLESTEDT, C .
NEUROSCIENCE LETTERS, 1991, 130 (01) :32-36
[2]  
AOKI C, 1990, ANN NY ACAD SCI, V611, P186
[3]  
AOKI C, 1989, J NEUROSCI, V9, P4333
[4]   Effect of neuropeptide Y (NPY) on oral ethanol intake in Wistar, alcohol-preferring (P), and -nonpreferring (NP) rats [J].
Badia-Elder, NE ;
Stewart, RB ;
Powrozek, TA ;
Roy, KF ;
Murphy, JM ;
Li, TK .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2001, 25 (03) :386-390
[5]   AN ARCUATO-PARAVENTRICULAR AND ARCUATO-DORSOMEDIAL HYPOTHALAMIC NEUROPEPTIDE Y-CONTAINING SYSTEM WHICH LACKS NORADRENALINE IN THE RAT [J].
BAI, FL ;
YAMANO, M ;
SHIOTANI, Y ;
EMSON, PC ;
SMITH, AD ;
POWELL, JF ;
TOHYAMA, M .
BRAIN RESEARCH, 1985, 331 (01) :172-175
[6]   Behavioral characterization of neuropeptide Y knockout mice [J].
Bannon, AW ;
Seda, J ;
Carmouche, M ;
Francis, JM ;
Norman, MH ;
Karbon, B ;
McCaleb, ML .
BRAIN RESEARCH, 2000, 868 (01) :79-87
[7]   Knock-out mice reveal a critical antiepileptic role for neuropeptide Y [J].
Baraban, SC ;
Hollopeter, G ;
Erickson, JC ;
Schwartzkroin, PA ;
Palmiter, RD .
JOURNAL OF NEUROSCIENCE, 1997, 17 (23) :8927-8936
[8]   CLONING AND FUNCTIONAL EXPRESSION OF A HUMAN Y4 SUBTYPE RECEPTOR FOR PANCREATIC-POLYPEPTIDE, NEUROPEPTIDE-Y, AND PEPTIDE YY [J].
BARD, JA ;
WALKER, MW ;
BRANCHEK, TA ;
WEINSHANK, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (45) :26762-26765
[9]   STRONG EVOLUTIONARY CONSERVATION OF NEUROPEPTIDE-Y - SEQUENCES OF CHICKEN, GOLDFISH, AND TORPEDO-MARMORATA DNA CLONES [J].
BLOMQVIST, AG ;
SODERBERG, C ;
LUNDELL, I ;
MILNER, RJ ;
LARHAMMAR, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (06) :2350-2354
[10]  
BROQUA P, 1995, BEHAV PHARMACOL, V6, P215